Profile data is unavailable for this security.
About the company
Sichuan Huiyu Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of anti-tumor and injection drugs. The Company’s products are mainly anti-tumor chemical injections, including pemetrexed disodium for injection, docetaxel injection, zoledronic acid injection, irinotecan hydrochloride injection, doxorubicin hydrochloride injection liquid and azacitidine for injection. The Company's products are mainly used in the clinical treatment of various adaptive diseases. The Company distributes its products both in the domestic market and to overseas markets.
- Revenue in CNY (TTM)1.12bn
- Net income in CNY278.20m
- Incorporated2010
- Employees1.36k
- LocationSichuan Huiyu Pharmaceutical Co LtdNo. 333, Hanyang Road, Shizhong DistrictNEIJIANG 641000ChinaCHN
- Phone+86 8 328808000
- Fax+86 8 328808111
- Websitehttps://www.huiyupharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cisen Pharmaceutical Co Ltd | 4.25bn | 529.01m | 6.45bn | 3.40k | 12.18 | 1.11 | -- | 1.52 | 1.17 | 1.17 | 9.41 | 12.89 | 0.585 | 2.15 | 6.06 | 1,250,659.00 | 7.33 | 6.94 | 9.10 | 8.56 | 57.72 | 56.27 | 12.53 | 10.77 | 2.63 | -- | 0.0329 | 33.42 | 9.75 | 3.22 | 48.92 | 0.697 | -15.19 | 10.72 |
| Jianmin Pharmaceutical Group Co Ltd | 3.98bn | 427.95m | 6.70bn | 2.50k | 15.61 | 2.80 | -- | 1.68 | 2.80 | 2.80 | 25.98 | 15.61 | 0.9793 | 6.99 | 4.16 | 1,592,652.00 | 10.62 | 10.87 | 18.49 | 19.11 | 42.34 | 43.04 | 10.84 | 9.32 | 1.38 | -- | 0.1492 | 37.15 | 15.72 | 14.28 | 27.78 | 45.05 | 8.77 | 43.10 |
| Sichuan Huiyu Pharmaceutical Co Ltd | 1.12bn | 278.20m | 6.82bn | 1.36k | 24.52 | 1.76 | -- | 6.09 | 0.6567 | 0.6567 | 2.64 | 9.16 | 0.2335 | 1.18 | 21.25 | 820,954.90 | 5.66 | 10.41 | 7.08 | 12.76 | 83.40 | 89.89 | 24.23 | 21.42 | 2.57 | -- | 0.1488 | 20.54 | -37.92 | 76.37 | -43.86 | -- | 66.72 | -- |
| Shanghai Fudan-Zhangjiang Bio-Pharm. Co | 691.62m | 105.20m | 6.90bn | 948.00 | 85.74 | 3.77 | -- | 9.97 | 0.0998 | 0.0998 | 0.6509 | 2.27 | 0.2482 | 1.53 | 1.50 | 729,558.10 | 3.76 | 7.03 | 4.43 | 9.05 | 90.24 | 92.17 | 15.15 | 17.26 | 6.06 | -- | 0.0048 | 26.31 | -17.50 | 2.78 | -21.28 | -0.6326 | 20.49 | -- |
| Wuhan Keqian Biology Co Ltd | 902.14m | 299.11m | 6.92bn | 923.00 | 23.19 | 1.79 | -- | 7.67 | 0.6404 | 0.6404 | 1.93 | 8.28 | 0.1968 | 2.44 | 2.47 | 977,402.10 | 6.51 | 13.29 | 7.62 | 15.49 | 63.87 | 76.49 | 33.08 | 45.71 | 4.71 | -- | 0.0209 | 24.76 | 6.27 | 7.67 | -3.32 | 0.3556 | 27.17 | -- |
| Lushang Freda Pharmaceutical Co Ltd | 3.99bn | 236.52m | 6.93bn | 3.65k | 29.31 | 1.70 | -- | 1.74 | 0.2327 | 0.2327 | 3.92 | 4.02 | 0.4694 | 0.7941 | 7.74 | 1,091,879.00 | 3.23 | 0.6992 | 5.93 | 5.12 | 48.73 | 20.23 | 6.87 | 3.45 | 2.96 | -- | 0.0896 | 40.33 | -64.65 | -12.29 | 567.44 | 13.36 | 44.40 | 14.87 |
| Zhejiang Ausun Pharmaceutical Co Ltd | 835.23m | 257.55m | 7.00bn | 1.17k | 27.10 | 3.05 | -- | 8.38 | 0.3111 | 0.3111 | 1.01 | 2.76 | 0.2788 | 1.09 | 2.84 | 711,439.10 | 8.60 | 9.38 | 11.35 | 12.84 | 54.34 | 53.09 | 30.84 | 27.14 | 2.00 | -- | 0.156 | 23.53 | 6.83 | 27.35 | 7.87 | 42.07 | 24.32 | 50.48 |
| JiangSu WuZhong Pharmactcl Devlpm Co Ltd | 2.38bn | -37.82m | 7.00bn | 1.05k | -- | 3.90 | -- | 2.94 | -0.055 | -0.055 | 3.34 | 2.52 | 0.5684 | 17.73 | 2.04 | 2,270,402.00 | -0.8772 | -2.92 | -1.79 | -5.30 | 28.07 | 28.14 | -1.54 | -5.77 | 1.46 | 0.5127 | 0.4841 | -- | 10.55 | 5.65 | 5.58 | -- | -19.08 | -- |
| China Animal Husbandry Industry Co., Ltd | 5.43bn | 87.90m | 7.02bn | 4.33k | 79.82 | 1.28 | -- | 1.29 | 0.0861 | 0.0861 | 5.31 | 5.37 | 0.6127 | 4.56 | 3.76 | 1,254,216.00 | 0.7085 | 6.23 | 1.00 | 9.01 | 16.42 | 24.29 | 1.16 | 8.69 | 1.54 | -- | 0.1909 | 31.20 | -8.24 | 4.04 | -26.73 | -0.6127 | 24.20 | -3.77 |
Data as of Nov 05 2024. Currency figures normalised to Sichuan Huiyu Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
6.39%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2024 | 13.76m | 3.25% |
| E Fund Management Co., Ltd.as of 30 Jun 2024 | 8.02m | 1.89% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2024 | 1.61m | 0.38% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.54m | 0.36% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2024 | 742.07k | 0.18% |
| Bank of China Investment Management Co., Ltd.as of 30 Jun 2024 | 725.66k | 0.17% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 373.47k | 0.09% |
| Broad Fund Management Co. Ltd.as of 30 Jun 2024 | 177.66k | 0.04% |
| China Asset Management Co., Ltd.as of 30 Jun 2024 | 100.40k | 0.02% |
| HFT Investment Management Co., Ltd.as of 30 Jun 2024 | 43.70k | 0.01% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
